ADRs End Higher
2018年6月29日 - 6:06AM
Dow Jones News
By Nishant Mohan
International stocks trading in New York closed mostly higher on
Thursday.
The BNY Mellon index of American depositary receipts gained
0.74% to 144.61. The European index increased 0.53% to 134.77, the
Asian index rose 0.88% to 173.44, the Latin American index rose
1.99% to 209.06 and the emerging markets index increased 1.2% to
305.11.
Shire PLC and AstraZeneca were among the companies with ADRs
that traded actively.
ADRs of Summit Therapeutics PLC (SMMT) fell 6.67% to $2.38
Thursday, continuing Wednesday's reaction to the company's canceled
development of its ezutromid treatment for Duchenne muscular
dystrophy.
Shire (SHPG) shares gained following the failure of Takeda
Pharmaceutical Co. to acquire the company. ADRs of the company grew
4.43% on Thursday to $168.41.
ADRs of Teva Pharmaceutical Industries (TEVA) gained 4.06% to
$24.60 a share following the drug company's announcement of
clinical trial data supporting its drug to prevent migraines.
AstraZeneca PLC (AZN) said it planned to sell licenses for its
antipsychotic drugs Seroquel and Seroquel XR to Luye Pharma Group
Ltd. in the U.K., China and other international markets. ADRs of
the company gained 1.01% to $34.90 a share Thursday.
Write to Nishant Mohan at nishant.mohan@wsj.com
(END) Dow Jones Newswires
June 28, 2018 16:51 ET (20:51 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Teva Pharmaceutical Indu... (NYSE:TEVA)
過去 株価チャート
から 6 2024 まで 7 2024
Teva Pharmaceutical Indu... (NYSE:TEVA)
過去 株価チャート
から 7 2023 まで 7 2024